TenNor Therapeutics (Suzhou)
Logotype for TenNor Therapeutics (Suzhou) Limited

TenNor Therapeutics (Suzhou) (6872) investor relations material

TenNor Therapeutics (Suzhou) H1 2026 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for TenNor Therapeutics (Suzhou) Limited
H1 2026 earnings summary26 Aug, 2026

Executive summary

  • Achieved significant progress in product pipeline, with rifasutenizol entering supplementary review for H. pylori and rifaquizinone advancing in clinical trials.

  • Completed IPO on the Hong Kong Stock Exchange, raising substantial capital for future development.

  • No commercialized products yet; focus remains on R&D and regulatory milestones.

Financial highlights

  • Loss for the period decreased to RMB64.2 million from RMB78.2 million year-over-year.

  • Research and development expenses rose to RMB31.3 million, up RMB5.0 million year-over-year.

  • Administrative expenses increased to RMB32.0 million, mainly due to listing expenses and share grants.

  • Cash and cash equivalents surged to RMB714.7 million from RMB183.8 million, driven by IPO proceeds.

  • No revenue generated from product sales during the period.

Outlook and guidance

  • Plans to accelerate clinical development and commercialization of core products, especially rifasutenizol and rifaquizinone.

  • Intends to expand indications and geographic reach, including U.S. and global markets.

  • Ongoing construction of in-house manufacturing facility, expected operational in 2028.

  • No interim dividend declared for the period.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
Research faster. Power your platform.
Latest events from TenNor Therapeutics (Suzhou)

    Next TenNor Therapeutics (Suzhou) earnings date

    Logotype for TenNor Therapeutics (Suzhou) Limited
    H2 202624 Mar, 2027
    TenNor Therapeutics (Suzhou)
    Cover every name on your watchlist this earnings season.
    Automations, AI chat, and live calls across 16,000+ companies.
    Book demo

    Next TenNor Therapeutics (Suzhou) earnings date

    Logotype for TenNor Therapeutics (Suzhou) Limited
    H2 202624 Mar, 2027

    The essential earnings season companion

    The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

    Live calls and transcripts

    Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

    Find what you need faster

    Search for any keyword across all transcripts simultaneously.

    Easily store key findings

    Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

    Your watchlist. Your dashboard.

    Follow the companies that matter to you. Get a personalized feed with real-time updates.

    Be the first to know

    Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

    Consensus estimates

    Access analyst consensus estimates, valuation multiples, and revenue segments splits.

    All IR material in one place

    The easiest way to stay updated during earnings season.

    Global coverage

    All events from public companies. Live and recorded.

    Just click and listen

    No webcast links. No manual registrations.

    Research anytime, anywhere

    Built for professionals. Loved by everyone. Try our free mobile app.

    excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
    App-store-avatar.png play-store-avatar.png
    Leroy DaleyApp Store
    One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
    play-store-avatar
    Eferix Drawings Google Play
    This is genuinely one of the cleanest and fastest finance apps out there to track the market.
    App-store-avatar.png play-store-avatar.png
    anuj283App Store
    excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
    App-store-avatar.png play-store-avatar.png
    Leroy DaleyApp Store
    One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
    play-store-avatar
    Eferix Drawings Google Play
    This is genuinely one of the cleanest and fastest finance apps out there to track the market.
    App-store-avatar.png play-store-avatar.png
    anuj283App Store
    I can't remember the last time an app had such a positive impact on my investment process.
    x-avatar
    @ankurshah47_ x.com
    Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
    App-store-avatar.png play-store-avatar.png
    Amina0781App Store
    Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
    x-avatar
    @theshortbearx.com
    I can't remember the last time an app had such a positive impact on my investment process.
    x-avatar
    @ankurshah47_ x.com
    Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
    App-store-avatar.png play-store-avatar.png
    Amina0781App Store
    Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
    x-avatar
    @theshortbearx.com

    Frequently asked questions

    Explore our global coverage